STEVENS CAPITAL MANAGEMENT LP
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1134813
RADNOR, PA
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$364,770
+$124,479 QoQ
Shares Held
585
+88.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#886
of 1,322 holders
Holding Since
Sep 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEVENS CAPITAL MANAGEMENT LP holds $642,789 across 2 Biotechnology names. REGN ranks #1 (56.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
585 | $364,770 | |
| 2 | MRNA |
Moderna, Inc.
|
3,970 | $278,019 |
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $364,770 | 585 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $240,291 | 311 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $792,238 | 1,409 | Shares | Sole | 2025-11-10 | |
| 2024-09-30 | $475,160 | 452 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $367,125 | 418 | Shares | Sole | 2024-02-02 | |
| 2023-03-31 | $828,243 | 1,008 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $561,319 | 778 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $586,228 | 851 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $413,199 | 699 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $2,783,108 | 4,407 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,610,989 | 2,662 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $202,030 | 427 | Shares | Sole | 2021-05-11 | |
| 2020-09-30 | $10,130,898 | 18,098 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||